✦ LIBER ✦

A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis

✍ Scribed by Yasuhiro Miyake; Yoshiaki Iwasaki; Ryo Terada; Takuya Nagano; Haruhiko Kobashi; Kohsaku Sakaguchi; Yasushi Shiratori

Book ID: 118087952
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 133 KB
Volume: 38
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2008.00329.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for hepatocellular carcinom

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1

✍ Teruko Hino-Arinaga, Tatsuya Ide, Ryoko Kuromatsu, Ichiro Miyajima, Kei Ogata, R 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 257 KB

Fas/Apo1 mutations and autoimmune lympho

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

✍ L Pensati; A Costanzo; A Ianni; D Accapezzato; R Iorio; G Natoli; R Nisini; C Al 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Efficacy of ursodeoxycholic acid in Japa

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

✍ JENNY HEATHCOTE 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Characterization of anti-histone antibod

Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis

✍ MING CHEN; MUTSUNORI SHIRAI; ALBERT J CZAJA; KAZUTAKA KUROKOHCHI; TATSUMI ARICHI 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Efficacy of ursodeoxycholic acid in Japa

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

✍ KIMIHIDE NAKAMURA; MASASHI YONEDA; SHIRO YOKOHAMA; KEISUKE TAMORI; YOICHI SATO; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

In type 1 autoimmune hepatitis, is cirrh

In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome?

✍ Sumita Verma; Allan Redeker 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

We read with interest the excellent article by Feld et al. 1 in which they quoted our work. A recent study by Verma et al. also found that patients with cirrhosis at presentation were more likely to die or develop complications of their liver disease during follow-up. 2 In fact, in our study individ